The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

Vogel, Birgit; Acevedo, Mónica; Appelman, Yolande; Merz, C. Noel Bairey; Chieffo, Alaide; Figtree, Gemma A.; Guerrero, Mayra; Kunadian, Vijay; Lam, Carolyn S.P.; Maas, Angela H.E.M.; Mihailidou, Anastasia S.; Olszanecka, Agnieszka; Poole, Jeanne E.; Saldarriaga, Clara; Saw, Jacqueline; Zühlke, Liesl; Mehran, Roxana

doi:10.1016/s0140-6736(21)00684-x

Cited by 783 publications

(819 citation statements)

References 511 publications

Supporting

Mentioning

724

Contrasting

Unclassified

Order By: Relevance

“…Despite dramatic declines in mortality rates over the past decades in most countries and globally [1,2], cardiovascular disease (CVD) remains the leading cause of premature deaths for both genders [3]. CVD, including coronary heart disease and stroke, accounts for nearly half of all premature deaths globally [1,2], and the economic burden of the condition is considerable in both developed and developing settings [4][5][6].…”

Section: Introductionmentioning

confidence: 99%

Global Gender Disparities in Premature Death from Cardiovascular Disease, and Their Associations with Country Capacity for Noncommunicable Disease Prevention and Control

Zhang

Jin

Jia

et al. 2021

IJERPH

View full text Add to dashboard Cite

This study aimed to describe the prevalence of gender disparity in cardiovascular disease and explore its association with a country’s capacity for controlling noncommunicable diseases. Study data were extracted from the Global Health Estimates, and the Noncommunicable Disease Country Capacity Survey. Age-standardized premature death rates from cardiovascular disease, defined as any death occurring from ages 30 to 70 years, were calculated. Univariate and multivariate general linear regression models were fitted to estimate the correlations between gender disparity and country capacity for noncommunicable disease control. Globally, the premature death rate from cardiovascular diseases was 35.6% higher among men than women in 2000, and the figure hardly changed from 2000 to 2016. The highest gender differences were observed in Europe and high-income countries. The existence of dedicated and multisectoral noncommunicable disease governance bodies and the availability of cardiovascular disease stratification in primary healthcare facilities were positively correlated with gender differences. Conclusively, gender disparities in premature death rates from cardiovascular diseases differed with economic conditions and across geographic regions, with higher relative differences observed in more developed countries. The effects of existing control measures may have plateaued in men but are ongoing among women, especially in more developed countries, widening the gender disparity.

show abstract

Section: Introductionmentioning

confidence: 99%

Global Gender Disparities in Premature Death from Cardiovascular Disease, and Their Associations with Country Capacity for Noncommunicable Disease Prevention and Control

Zhang

Jin

Jia

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…Cardiovascular disease (CVD) is the leading cause of death in men and women worldwide. 1 Although there have been significant advances in reducing CVD-related morbidity and mortality in both sexes, current guideline-directed therapies are based on data that predominantly include male patients. 2 Consequently, in CVD management, female patients might currently be treated equally (the same), however, they are not treated based on equity (i.e.…”

mentioning

confidence: 99%

The importance of achieving sex- and gender-based equity in clinical trials: a call to action

Diemen

Verdonk

Chieffo

et al. 2021

European Heart Journal

Self Cite

View full text Add to dashboard Cite

“…In the recently published Lancet women and cardiovascular disease commission, Vogel et al note that despite the recognized influence of sex and gendered factors on women"s heart health, there has been a "confounding stagnation in the overall reduction of cardiovascular disease burden for women" [37]. More importantly they note that distinct strategies are urgently needed to tackle inequities and advance solutions regarding sex-specific differences in outcomes.…”

Section: Discussionmentioning

confidence: 99%

Sex Differences in the Care Experiences of Patients Hospitalized Due to Ischemic Heart Disease in Alberta, Canada

et al. 2021

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

Cited by 783 publications

References 511 publications

Global Gender Disparities in Premature Death from Cardiovascular Disease, and Their Associations with Country Capacity for Noncommunicable Disease Prevention and Control

Global Gender Disparities in Premature Death from Cardiovascular Disease, and Their Associations with Country Capacity for Noncommunicable Disease Prevention and Control

The importance of achieving sex- and gender-based equity in clinical trials: a call to action

Sex Differences in the Care Experiences of Patients Hospitalized Due to Ischemic Heart Disease in Alberta, Canada

Contact Info

Product

Resources

About